Three-Pronged attack on deadly lymphoma shows promise
Disease control
Not yet recruiting
This study is testing whether combining three different drugs works better than current treatments for an aggressive type of blood cancer called NK/T-cell lymphoma. The trial will involve 40 adults with advanced disease who haven't had prior treatment. Researchers hope this combi…
Phase: PHASE2 • Sponsor: LIANG WANG • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC